Infections associated with clozapine: a pharmacovigilance study using VigiBase(®)

por Chrétien, Basile, Brazo, Perrine, Da Silva, Angélique, Sassier, Marion, Dolladille, Charles, Lelong-Boulouard, Véronique, Alexandre, Joachim, Fedrizzi, Sophie
Publicado 2023

Neurocognitive impairment in females with breast cancer treated with endocrine therapy and CDK4/6 inhibitors: a pharmacovigilance study using the World Health Organization’s databa...

por Prevost, Rachel, Chretien, Basile, Minoc, Elise-Marie, Dolladille, Charles, Da-Silva, Angélique, Nehme, Ahmad, Joly, Florence, Lelong-Boulouard, Véronique, Bastien, Etienne
Publicado 2023

Atrial Fibrillation Incidence Associated With Exposure to Anticancer Drugs Used as Monotherapy in Clinical Trials

por Alexandre, Joachim, Boismoreau, Louis, Morice, Pierre-Marie, Sassier, Marion, Da-Silva, Angélique, Plane, Anne-Flore, Font, Jonaz, Milliez, Paul, Legallois, Damien, Dolladille, Charles
Publicado 2023

Does COVID‐19 pandemic impact cancer outcomes in metastatic setting? A comparative cohort study among metastatic patients treated at day care hospital

por Quilan, Florian, Lequesne, Justine, Cherifi, François, Bastien, Etienne, Morel, Adeline, Delcambre, Corinne, Da Silva, Angélique, Grellard, Jean‐Michel, Leconte, Alexandra, Faveyrial, Audrey, Clarisse, Bénédicte, Joly, Florence
Publicado 2023

How to improve adherence of guidelines for localized testicular cancer surveillance: A Delphi consensus study

por Da Silva, Angélique, Fléchon, Aude, Coquan, Elodie, Planchamp, François, Culine, Stéphane, Murez, Thibaut, Méjean, Arnaud, Pasquier, David, Chevreau, Christine, Fizazi, Karim, Thiery-Vuilemin, Antoine, Joly, Florence
Publicado 2022

Pretreatment neutrophil to lymphocyte ratio as prognostic factor in metastatic breast cancer treated with cyclin dependent kinase 4/6 inhibitors

por Rottier, Pauline, Emile, George, Johnson, Alison, Levy, Christelle, Allouache, Djelila, Hrab, Ioana, Segura, Carine, Morel, Adeline, Villemin, Maud, Dubot-Poitelon, Coraline, Boismoreau, Louis, Cherifi, François, Lequesne, Justine, Da Silva, Angélique
Publicado 2023

HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer

por Cherifi, François, Da Silva, Angélique, Johnson, Alison, Blanc-Fournier, Cécile, Abramovici, Olivia, Broyelle, Antonin, Levy, Christelle, Allouache, Djelila, Hrab, Ioana, Segura, Carine, Morel, Adeline, Villemin, Maud, Boscher, Clémence, Dubot-Poitelon, Coraline, Rottier, Pauline, Lequesne, Justine, Emile, George
Publicado 2022